Table 2 Comorbidities of the study population
95% CI | p | |||||
|---|---|---|---|---|---|---|
S3+ | S2+ /S3– | Absolute difference | Lower bound | Upper bound | ||
Nicotine | 194 (25.5) | 67 (33.8) | − 8.3 | − 15.7 | − 1.1 | 0.019 |
Alcohol abuse | 152 (18.5) | 23 (11.3) | 7.2 | 1.8 | 12.0 | 0.014 |
NYHA III/IV | 242 (26.6) | 70 (31.3) | − 4.7 | − 11.5 | 1.9 | 0.159 |
Organ transplantation | 19 (5.1) | 8 (10.5) | − 5.4 | − 13.6 | 1.3 | 0.074 |
Stem cell transplantation | 7 (1.9) | 0 (0) | 1.9 | − 2.0 | 3.8 | 0.226 |
Malignancy | 174 (28.9) | 50 (21.6) | 7.3 | 1.0 | 13.1 | 0.026 |
Metastatic malignancy | 100 (10.6) | 18 (7.8) | 2.8 | − 1.5 | 6.5 | 0.209 |
Hematologic condition | 111 (11.7) | 41 (17.7) | − 6.1 | − 11.6 | − 0.9 | 0.013 |
Chronic Liver disease | 153 (16.2) | 13 (5.6) | 10.6 | 6.4 | 14.1 | < 0.001 |
Pulmonary disease | 162 (17.2) | 54 (23.3) | − 6.1 | − 12.2 | − 0.3 | 0.032 |
Chronic kidney disease | 206 (21.7) | 63 (27.3) | − 5.6 | − 12.0 | 0.6 | 0.071 |
Patient on dialysis | 24 (2.5) | 11 (4.8) | − 2.2 | − 5.5 | 0.5 | 0.073 |
Diabetes mellitus | 202 (21.2) | 48 (20.7) | 0.5 | − 5.5 | 6.2 | 0.854 |
Hypertension | 305 (32.2) | 78 (33.8) | − 1.6 | − 8.5 | 5.1 | 0.643 |
Vascular disease | 160 (16.9) | 45 (19.5) | − 2.6 | − 8.4 | 2.8 | 0.349 |
Ischemic stroke | 50 (5.3) | 11 (4.8) | 0.5 | − 3.0 | 3.4 | 0.753 |
Coronary disease | 180 (19.1) | 45 (19.4) | − 0.3 | − 6.2 | 5.2 | 0.909 |